We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$190M
AUM Growth
+$20.7M
Cap. Flow
+$20.1M
Cap. Flow %
10.54%
Top 10 Hldgs %
5.58%
Holding
804
New
341
Increased
82
Reduced
54
Closed
326

Top Buys

Rank Stock Value
1
UGI icon
UGI
UGI
+$1.2M
2
GILD icon
Gilead Sciences
GILD
+$1.06M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.05M
4
WM icon
Waste Management
WM
+$1.04M
5
H icon
Hyatt Hotels
H
+$1.03M

Top Sells

Rank Stock Value
1
IP icon
International Paper
IP
+$1.5M
2
FTNT icon
Fortinet
FTNT
+$1.03M
3
CHKP icon
Check Point Software Technologies
CHKP
+$978K
4
ALB icon
Albemarle
ALB
+$881K
5
MOH icon
Molina Healthcare
MOH
+$869K

Sector Composition

Rank Sector Weight
1 Technology 15.74%
2 Healthcare 13.65%
3 Consumer Discretionary 12.28%
4 Industrials 11.23%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVP
451
DELISTED
Avon Products, Inc.
AVP
$151K 0.08%
30,000
+14,100
+89% +$81.9K
BB icon
452
BlackBerry
BB
$5.01B
$150K 0.08%
+21,700
New +$161K
HLX icon
453
Helix Energy Solutions
HLX
$1.46B
$145K 0.08%
+16,400
New +$158K
OPK icon
454
Opko Health
OPK
$921M
$141K 0.07%
+15,200
New +$157K
VRA icon
455
Vera Bradley
VRA
$105M
$139K 0.07%
11,900
+300
+3% +$4.13K
LOCO icon
456
El Pollo Loco
LOCO
$485M
$138K 0.07%
+11,200
New +$138K
SEM
457
DELISTED
Select Medical
SEM
$135K 0.07%
+18,931
New +$132K
OCLR
458
DELISTED
Oclaro Inc.
OCLR
$131K 0.07%
14,600
+4,300
+42% +$37.2K
DPLO
459
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$127K 0.07%
+10,100
New +$188K
ATEN icon
460
A10 Networks
ATEN
$2.47B
$118K 0.06%
+14,200
New +$122K
NMIH icon
461
NMI Holdings
NMIH
$3.25B
$118K 0.06%
11,100
-3,000
-21% -$26.5K
DHX icon
462
DHI Group
DHX
$166M
$109K 0.06%
17,400
+7,000
+67% +$45K
PGNX
463
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$103K 0.05%
+11,900
New +$88K
GNL icon
464
Global Net Lease
GNL
$1.87B
$98K 0.05%
+4,167
New +$95.4K
XRX icon
465
Xerox
XRX
$337M
$98K 0.05%
+4,250
New +$106K
ARCO icon
466
Arcos Dorados Holdings
ARCO
$1.73B
$95K 0.05%
+18,090
New +$103K
ISEE
467
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$95K 0.05%
+19,600
New +$582K
HAPN
468
Happen Inc
HAPN
$2.08B
$92K 0.05%
+3,500
New +$96.1K
FIT
469
DELISTED
Fitbit, Inc. Class A common stock
FIT
$91K 0.05%
+12,400
New +$127K
CCXI
470
DELISTED
ChemoCentryx, Inc.
CCXI
$90K 0.05%
+12,100
New +$87.1K
ANH
471
DELISTED
Anworth Mortgage Asset Corporation
ANH
$87K 0.05%
+16,800
New +$84.8K
MACK
472
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$87K 0.05%
+2,707
New +$115K
TGTX icon
473
TG Therapeutics
TGTX
$8.58B
$86K 0.05%
+18,600
New +$109K
STKL
474
DELISTED
SunOpta
STKL
$85K 0.04%
+12,100
New +$84.2K
CEMP
475
DELISTED
Cempra, Inc.
CEMP
$85K 0.04%
+30,400
New +$369K
17 18
19
20 21

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q4 2016 Portfolio in Review

As of Q4 2016, Fox Run Management held 804 positions worth $190M, up 12% from $170M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Fox Run Management deployed $20.1M of net new capital in Q4 2016, opening 341 new positions and adding to 82 existing holdings. Its largest new stake was UGI: 26,700 shares worth $1.23M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was QIAGEN NV, an estimated $819K trimmed.

  • Fox Run Management's largest Q4 2016 buy was UGI: 26,700 shares worth $1.23M.
  • Fox Run Management added most to Neurocrine Biosciences in Q4 2016, an estimated $928K increase.
  • Fox Run Management's biggest Q4 2016 reduction was QIAGEN NV, cutting an estimated $819K.
  • Fox Run Management fully exited International Paper in Q4 2016, selling an estimated $1.5M.
  • Fox Run Management's ten largest holdings make up 5.6% of its $190M portfolio in Q4 2016.
  • Fox Run Management opened 341 new positions and closed 326 in Q4 2016.
  • Fox Run Management's portfolio value rose 12% quarter-over-quarter to $190M.

Based on Fox Run Management's 13F filing for Q4 2016, filed 10 Jan 2017.